期刊文献+

γ-干扰素及外源性吲哚对泌尿生殖道沙眼衣原体生长影响的探讨 被引量:1

Effect of interferon-γ and exogenous indole on the growth of Chlamydia trachomatis
下载PDF
导出
摘要 目的探讨外源性吲哚及γ-干扰素对国内沙眼衣原体优势株E-UW-5/Cx型标准株及临床株生长的影响,并与国外优势株D-UW-5/Cx进行比较。方法分别用DMEM-10、DMEM-10加5ng/mL重组人γ-干扰素和DMEM-10加5ng/mL重组人γ-干扰素及50μmol外源性吲哚三种细胞培养液培养沙眼衣原体至48h,甲醇固定后计数包涵体,观察γ-干扰素及外源性吲哚对E型、D型沙眼衣原体标准株及临床株生长的影响。结果 DMEM-10+IFN组衣原体包涵体计数明显低于DMEM-10组和DMEM-10+IFN+IND组,差异有统计学意义,P<0.05;DMEM-10组和DMEM-10+IFN+IND组包涵体计数差异无统计学意义;E型标准株、临床株与D型标准株、临床株之间差异无统计学意义,P>0.05。结论在IFN-γ作用下,沙眼衣原体的生长繁殖受到明显抑制,加入外源性吲哚后,泌尿生殖道沙眼衣原体可以逃逸IFN-γ介导的清除作用,恢复其感染活力。 We investigated the effects of 7-interferon and exogenous indole on the growth of domestic dominant standard strains and clinical strains of Chlamydia trachomatis E-UW-5/Cx, and compared with the dominant strains of D-UW-5/Cx a- broad. We used DMEM-10, DMEM-10 containing 5 ng/mL recombinant human interferon gamma (referred to as DMEM-10q- IFN) and DMEM-10 containing 5 ng/mL recombinant human interferon gamma and 50 μM exogenous indole (referred to as DMEM-10+IFN+IND) to culture C. trachornatis, and then we fixed it with methanol to count inclusions after 48 hours, ohserving the influence of r-interferon and exogenous indole on the growth of C. trachomatis standard strains(E, D) and clinical strains. Results showed that the count of Chlamydia inclusion bodies in DMEM 10+IFN group was significantly lower than others (P〈0.05); no significant difference was found (P〉0.05) between the count of DMEM-10 group between DMEM-10+ IFN+IND group. There were no significant difference between the E and D standard or clinical strains (P〉0.05). Under the effect of IFN 7, the growth of domestic dominant strain E-UW-5/Cx C. trachomatis was significantly inhibited. After adding exogenous indole, C. trachomatis can escape the scavenging activity of IFN-γ to restore the infection vitality.
出处 《中国人兽共患病学报》 CAS CSCD 北大核心 2017年第2期131-135,共5页 Chinese Journal of Zoonoses
基金 山东省自然科学基金项目(No.ZR2011HL009) 泰安市科技发展计划项目(No.2016NS1167)联合资助~~
关键词 沙眼衣原体 HELA细胞 Γ-干扰素 外源性吲哚 Chlamydia trachomatis Hela cell interferon-γ exogenous indole
  • 相关文献

参考文献2

二级参考文献42

  • 1Bas S, Kvien T K, Buch N, et al. Lower level of synovial fluid interferon-gamma in HLA-B27-positive than in HLA-B27negative patients with Chlamydia trachomatis reactive arthritis[J]. Rheumatology (Oxford) ,2003,42(3):461-467.
  • 2Voorhis W S, Barrett L K, Losgrove S Y T, et al. Repeated Chlammydia trachomatis Infection of Macaca nemestrina fallopian tubes produces a Th1-like cytokine response associated with fibrosis and scarring[J]. Infection and Immunity, 1997,65(6):2175-2182.
  • 3Yang X, Brunham R C. T lymphocyte immunity in host defense against chlamydia trachomatis and its implication for vaccine development[J]. Can J Infect Dis, 1998,9:99-109.
  • 4Perfettini J L, Darville T, Gashelin G, et al. EffeCT of chlamydiatrachomatis infeCTion and subsequent TNF-α ecretion on apop2tosis in the murine genital traCT [J]. Infect Immun, 2000,68: 2237-2244.
  • 5Darville T, Andrews C W, Rank R G. Does inhibition of tumornecroses factor alpha affeCT chlamydial genital traCT infeCTion inmice and guinea pigs[J]. Infect Immun, 2000,68(9):5299-5305.
  • 6Kass E, Parker J, Schlom, et al. Comparative studiesof the effects of recombiant GM-CSF and GM-CSF administered via a poxvirus to enhancethe concent rat ion of ant igen p resenting cells in regional lymphnodes[J]. Cytokine,2000,12(7):960-971.
  • 7Lu H, Xing Z, Brunham R C. GM-CSF transgene-based adjuvant allows the establishment of protective mucosal immunity following vaccination with inactivated Chlamydia trachomatis[J]. J Immunol,2002,169(11):6324-6331.
  • 8Morrison S G, Morrison R P. In situ analysis of the evolution of the primary immune response in murine chlamydia trachomatis genitaltract infection[J]. Infect Immun, 2000,68(5):2870-2879.
  • 9Lu H, Yang X, Takeda K. Chlamydia trachomatis mouse pneumonitis lung infection in IL-18 and IL-12 knockout mice:IL-12 is dominant over IL-18 for protective immunity[J]. Mol Med,2000,6(7):604-612.
  • 10Yang X. Role of cytokines in Chlamydia trachomatis protective immunity and immunopathology[J]. Curr Pharm Des,2003,9(1):67-73.

共引文献7

同被引文献6

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部